ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
rdf:type |
node1 |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
rdf:type |
prov:Person |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
owl:sameAs |
https://semopenalex.org/author/A5107899161 |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
foaf:familyName |
Yuan |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
foaf:givenName |
Yan |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
foaf:name |
Yan Yuan |
ripekg:retraction-notice/36953Structural characterization and anti-inflammatory potency of Mesobuthus martensii Karsch oligopeptides in lipopolysaccharide (LPS)-induced RAW264.7 macrophages |
ripe:concerns |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial |
dcterms:creator |
ripekg:author/RIPEAU410921BFD9AE98FEYan Yuan |